Skin diseases are among the most common health ... Although most of the chronic skin conditions, such as atopic eczema, psoriasis, vitiligo and leg ulcers, are not immediately life-threatening ...

Cutaneous disease is a frequent cause of morbidity in the homeless. Several skin conditions, both infectious and noninfectious, have been described in the homeless population including trauma ...

A new medicine, Nenolizumab, has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) to treat two ...

There are several conditions that may make you look ... You could need antibiotics to clear up your skin. This lifelong disease causes your immune system – your body's defense against germs ...

Skin conditions can also be a side effect of treatments for autoimmune diseases. For example, infliximab (Remicade), one of the medications doctors prescribe to treat Crohn’s disease ...

Having itchy skin is usually nothing to worry about, but if it persists it could indicate something more serious.

Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a chronic inflammatory skin condition of the skin, hair, nails, mouth and ...

Despite the recent rise in herbal supplement use, research suggests certain supplements may pose risks for patients with ...

Stress has a huge impact on the way our skin ages. Stress hormones speed up the ageing process, causing more fine lines and wrinkles.

("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today announced that it has entered into ...

Psoriasis and hidradenitis suppurativa are both skin diseases that can impact cardiovascular health. Heart disease is the leading cause of death in America, so it's important to have a yearly skin ...

About Dermata Therapeutics Dermata Therapeutics is a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin diseases and conditions. Dermata's lead product ...